36 results on '"Yamashita T"'
Search Results
2. Very late-onset reversible cardiomyopathy in patients with chronic GvHD
3. A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation
4. LATE MORTALITY AND CAUSE OF DEATH AMONG LONG SURVIVORS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: PH-P353
5. INFLUENCE OF GRAFT-VERSUS-HOST DISEASE ON LATE RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES: A NATIONWIDE RETROSPECTIVE STUDY FROM THE LATE COMPLICATIONS AND QUALITY-OF-LIFE WORKING GROUP OF JSHCT: PH-O156
6. Clinical outcomes of allogeneic haematopoietic stem cell transplantation with intravenous busulfan-based reducedintensity conditioning for acute myeloid leukaemia: a nationwide retrospective study from the adult AML working group of JSHCT: O380
7. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage
8. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT
9. Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation
10. Third allogeneic stem cell transplantation for the treatment of acute leukaemia: P1215
11. Long-term effect of kidney shielding during total body irradiation: a single-centre experience: P690
12. A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
13. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
14. Cystatin C level as a marker of renal function in haematopoietic stem cell transplantation: R1245
15. Clinical characteristics of early-onset acute graft-versushost disease after allogeneic haematopoietic stem cell transplantation: R1228
16. Comparison of allogeneic haematopoietic cell transplantation and chemotherapy in adult patients with non-M3 AML staying in CR1: a retrospective nation-wide survey: O136
17. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
18. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation
19. A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan
20. Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation
21. Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation
22. Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation
23. A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan
24. A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F
25. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT
26. Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation
27. A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
28. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
29. Prevention of accelerated presbycusis by bone marrow transplantation in senescence-accelerated mice
30. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
31. A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F
32. A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation.
33. Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.
34. Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan.
35. Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor.
36. Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.